Authors
Latest:
OTC Progestin-Only Pill May Prevent Unintended PregnanciesAn over-the-counter (OTC) progestin only pill (POP) could potentially reduce the overall number of unintended pregnancies in the United States.
Latest:
Safinamide (Xadago): Approved as Add-On for Parkinson’sXadago has been approved as a supplementary medication for patients with Parkinson's disease who are having "off" episodes or whose disease is progressing.
Latest:
Ocrelizumab for Multiple SclerosisThe FDA has approved ocrelizumab for treating relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.
Latest:
Utilizing a PSAO's Strategic Alliance for Success During Open EnrollmentA high performing Pharmacy Services Administrative Organization (PSAO) actualizes its value proposition to its participating pharmacies by entering into viable strategic partnerships that add value to an independent pharmacy’s workflow processes.
Latest:
Ixazomib for multiple myelomaFDA approved ixazomib (Ninlaro, Takeda) in combination with lenalidomide and dexamethasone
Latest:
Delafloxacin (Baxdela) for Acute Bacterial Skin InfectionsDelafloxacin (Baxdela) for treatment of acute bacterial skin and skin structure infections including cellulitis, wound infection, major cutaneous abscess, and burn infection.
Latest:
New combo therapy for chronic heart failureEntresto® is a newly approved combination of sacubitril, a neprilysin inhibitor, and valsartan, an angiotensin II receptor blocker (ARB) for patients who have chronic heart failure NYHA Class II-IV and reduced ejection fraction.
Latest:
Targeting LDL via PCSK-9 from a Different PathwayA drug underdevelopment may provide another pathway to lowering LDL levels.
Latest:
When IV acetaminophen costs skyrocketed, one health system did some new mathA community hospital study found that a procedural change could save some big bucks.
Latest:
When IV acetaminophen costs skyrocketed, one health system did some new mathA community hospital study found that a procedural change could save some big bucks.
Latest:
Vitamin D analogues and corticosteroids in the treatment of plaque psoriasisTopical treatment with vitamin D analogs and corticosteroids is the mainstay of first-line therapy for patients with localized psoriasis.
Latest:
7 tips for surviving a pharmacy robberyEven when a pharmacy takes adequate precautionary steps, there’s no guarantee that a pharmacist or pharmacy technician still might not find himself or herself facing an armed robber. So what should pharmacy workers do when during a robbery?
Latest:
U.B. and beyond: Nine lives in pharmacyWhen you find a good thing, pass it on. Here's a story of nine pharmacists who have done exactly that.
Latest:
Too many pharmacy schools? One dean says noRecently, the Chapman University School of Pharmacy (CUSP) received its accreditation as the first pharmacy school in Orange County, CA. It will begin accepting students in September 2015 for an eight trimester accelerated doctor of pharmacy degree program. We asked CUSP’s Founding Dean Ronald P. Jordan, RPh, FAPhA, to address concerns of pharmacists that an abundance of pharmacy schools is producing a glut of pharmacists, higher industry unemployment, and will eventually drive down salaries.
Latest:
Provider status: Important to pharmacists, critical to patientsValidation through inclusion in Medicare Part B could lead to recognition of pharmacists as healthcare providers across the board.
Latest:
Pathways through pharmacy: Bob, the Pharmacy Man!Bob Benton's life in pharmacy has brought him satisfaction and enjoyment of his profession. And he's done a lot of people a lot of good.
Latest:
Health System Specialty Pharmacies Enhance Services and SavingsBy 2020, industry experts believe specialty drugs will account for 50% of U.S. spending on pharmaceuticals.
Latest:
Why I filed a class action lawsuit against WalmartCalifornia pharmacist Afrouz Nikmanesh recently filed a class-action lawsuit against Walmart, alleging the retail giant cheated her and her colleagues out of work breaks and overtime pay.
Latest:
Pharma needs to refocus on what matters mostThree of the most heavily invested players in the pharmaceutical industry are at odds. Pharma manufacturers need to recoup R&D costs and demonstrate accountability to leadership and shareholders, keeping drug prices as high as possible before their patents expire. PBMs are responsible for driving down costs for their plan sponsors, frequently engaging in hard negotiations with manufacturers. Pharmacists are often afterthoughts to the conversation, even though they are arguably the healthcare providers with more ability to influence patient outcomes and maximize the value of high-cost medication therapies than any other member of the care continuum.
Latest:
Provider status is fine and dandy, but pharmacists need to get paidIn the pharmacist's hierarchy of needs, which comes first? Provider status? Or getting paid for the work you're doing right now?
Latest:
Prevent Rx drug abuse: Lock up those medsWhat if pharmacies give a lockbox to every patient taking a controlled medication? This project aims to find out.
Latest:
Does your pharmacy comply with quality assurance requirements?Some tips on what constitutes a QA and how to comply with pharmacy law when creating one.
Latest:
For patient-focused attention, call a clinical pharmacistAdding pharmacists to the care team will result in better patient outcomes, lower payer costs, relief for physicians, and better use of pharmacists' skills and experience. It's a no-brainer.
